Clearance Summary
SeaSpine® Vu aPOD Prime NanoMetalene® Intervertebral Body Fusion Device received FDA 510(k) clearance under submission number K162351, sponsored by SeaSpine Orthopedics Corporation. The device was reviewed via the Traditional premarket notification pathway and assigned to the Orthopedic review panel. The statutory decision date of record is 2016-12-01.
- Submission: K162351
- Applicant / Sponsor: SeaSpine Orthopedics Corporation
- Clearance pathway: Traditional
- Review panel: Orthopedic
- Device class: Class II
- Regulation citation: 21 CFR 888.3080
- Decision date: 2016-12-01
Classification & Regulation
This clearance is catalogued under FDA product code OVD and 21 CFR 888.3080, within the Orthopedic review panel as a Class II device.